Recently, OxTium Technology and Zeno Future Biotechnology (Qingdao) Co., Ltd. (hereinafter referred to as "Zeno Technology") officially entered into a strategic partnership.
The two parties have engaged in deep collaboration across industrial strain creation, cell factory construction, and biomanufacturing industrialization, connecting the entire chain from rational strain design, strain screening, and multi-omics analysis to process scale-up, while integrating intelligent fermentation analysis capabilities to refine the full-process R&D system for biomanufacturing.
Currently, AI for Science is accelerating its penetration into the core segments of biomanufacturing. For biomanufacturing, intelligence must not stop at target discovery and strain design on the R&D side; it must go deeper into real industrial production sites and break down the physical barriers between strains, processes, equipment, and data.
Zeno Technology possesses a mature synthetic biology wet-lab platform and industrialization experience, with deep expertise in engineering strain development for high-value natural products; OxTium Technology leverages multi-omics and metabolic network analysis capabilities to provide R&D data, reduce the trial-and-error cost of strain iteration, and support strain performance optimization and precise fermentation process iteration.
Through this strong alliance, the two parties are jointly advancing the industrialization of synthetic biology technologies and empowering green biomanufacturing innovation.
Based on the core strengths of both parties, this collaboration focuses on "AI-empowered biomanufacturing" as a key entry point for joint research:
Building full-process intelligent modeling and dynamic parameter optimization for fermentation;
Accelerating process scale-up and reducing trial-and-error costs;
Accumulating industrial-grade data assets and a self-evolving closed loop.
"The endgame of synthetic biology lies in scaled implementation and industrial competitiveness. Zeno has accumulated rich frontline engineering experience and process data in industrial scenarios, while OxTium Technology has deep technical insight and engineering strength in AI for Science." Regarding this strategic collaboration, Dr. Zhu Tianze, Founder & CEO of Zeno Technology, stated that he looks forward to both parties using intelligent tools to overcome process challenges, improve production efficiency and yield rates, and set an industry benchmark for the digital and intelligent transformation of biomanufacturing.
Dr. Deng Siwei, Co-founder & CTO of OxTium Technology, stated that OxTium Technology has already accumulated a certain number of customers and experience in projects such as "AI + Biomanufacturing." "When the insight of algorithms is deeply combined with solid industrial engineering capabilities, AI will become the most reliable assistant for production engineers, injecting more certain growth momentum into biomanufacturing."
From scientific mechanisms to industrial implementation, this partnership marks another key milestone for OxTium Technology in deepening industrial collaboration and advancing AI technology into real biomanufacturing scenarios.
In the future, OxTium Technology will continue to join hands with outstanding industrial pioneer partners such as Zeno Technology to bring AI technology from laboratory algorithms into real biomanufacturing factories, accelerating the implementation of intelligent capabilities in more real research and industrial scenarios, and injecting lasting momentum into the high-quality and intelligent upgrading of China's biomanufacturing industry.